August 12, 2020 |
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !
Our Director of Rare Disease, Gavin Jones, is looking forward to his conversation with Emily Reuben (m.Crossley) and Betsy Bogard at #WODCUSA2020! He values the opportunity to speak to people at the front line of efforts to bring gene therapies to patients living with a rare disease and is sure the audience will do too. They will be sharing their thoughts based on the core themes of education and value demonstration that OPEN Health recently shared in a white paper.
This demonstrating our commitment to leading the conversation on how effective healthcare communications, and tools that enable them, can lead to faster and sustained patient access to gene and other advanced therapies. We brought together experience and capabilities from across our practices to develop broad thinking on ‘Succeeding with Star Wars Medicine – translating the science and value of gene therapy to key stakeholders’. The thinking is based on three key foundations:
Please find a short video of our Director of Rare Disease, Gavin Jones, describing why we have invested in this white paper and what you can expect from our recommendations.
To arrange a virtual presentation to discuss the findings and to receive a copy of the white paper please contact: gavinjones@openhealthgroup.com
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health today announced the appointment of Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and support clients…
OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.
OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and scientific excellence.
OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of…
OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for…
Discover the key takeaways from OPEN Health’s latest whitepaper: “The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy.”
OPEN Health is excited to announce the upcoming presentation of a collection of research supported by its Scientific Buyout Program. This initiative empowers our team members to dedicate time toward…
OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine…
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer
